APO Research
Talk to an analyst

APO RESEARCH · REPORT

Vaginal Fungi Infections Treatment

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Vaginal Fungi Infections Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025199 pages

Choose your research edition.

Industry ResearchVaginal Fungi Infections Treatment Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Vaginal Fungi Infections Treatment Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Vaginal Fungi Infections Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vaginal Fungi Infections Treatment Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Vaginal Fungi Infections Treatment Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Vaginal Fungi Infections Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Vaginal Fungi Infections Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Vaginal Fungi Infections Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Vaginal Fungi Infections Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Vaginal Fungi Infections Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Vaginal Fungi Infections Treatment include ANI Pharmaceuticals, Aurobindo Pharma Limited, Bausch Health Companies Inc, Dr. Reddy's Laboratories, Glenmark Pharmaceuticals Limited, Hikma Pharmaceuticals Plc, Lupin Limited, Mycovia Pharmaceuticals and PEPTONIC medical AB, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Vaginal Fungi Infections Treatment market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Vaginal Fungi Infections Treatment and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Vaginal Fungi Infections Treatment revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Vaginal Fungi Infections Treatment market size, projected growth trends, production technologies, key applications, and end-use industries.

Vaginal Fungi Infections Treatment Segment by Company

ANI Pharmaceuticals

Aurobindo Pharma Limited

Bausch Health Companies Inc

Dr. Reddy's Laboratories

Glenmark Pharmaceuticals Limited

Hikma Pharmaceuticals Plc

Lupin Limited

Mycovia Pharmaceuticals

PEPTONIC medical AB

SCYNEXIS

Unique Pharmaceuticals

Pfizer Inc.

Vaginal Fungi Infections Treatment Segment by Type

Flucytosine

Fluconazole

Nystatin

Others

Vaginal Fungi Infections Treatment Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Vaginal Fungi Infections Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vaginal Fungi Infections Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vaginal Fungi Infections Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vaginal Fungi Infections Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Vaginal Fungi Infections Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Vaginal Fungi Infections Treatment industry.

Chapter 3: Detailed analysis of Vaginal Fungi Infections Treatment companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Vaginal Fungi Infections Treatmentrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Vaginal Fungi Infections Treatment Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Flucytosine Table 3. Key Players of Fluconazole Table 4. Key Players of Nystatin Table 3. Key Players of Others Table 4. Global Vaginal Fungi Infections Treatment Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Pharmacies Table 6. Key Players of Online Pharmacies Table 7. Key Players of Retail Pharmacies Table 8. Global Vaginal Fungi Infections Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Vaginal Fungi Infections Treatment Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Vaginal Fungi Infections Treatment Market Share by Region (2021-2026) Table 11. Global Vaginal Fungi Infections Treatment Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Vaginal Fungi Infections Treatment Market Share by Region (2027-2032) Table 13. Vaginal Fungi Infections Treatment Industry Trends Table 14. Vaginal Fungi Infections Treatment Industry Drivers Table 15. Vaginal Fungi Infections Treatment Industry Opportunities and Challenges Table 16. Vaginal Fungi Infections Treatment Industry Restraints Table 17. Global Vaginal Fungi Infections Treatment Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Vaginal Fungi Infections Treatment Revenue Market Share by Company (2021-2026) Table 19. Global Vaginal Fungi Infections Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Vaginal Fungi Infections Treatment Key Company Head Office and Area Served Table 21. Global Vaginal Fungi Infections Treatment Company, Product Type & Application Table 22. Global Vaginal Fungi Infections Treatment Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Vaginal Fungi Infections Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Vaginal Fungi Infections Treatment Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Vaginal Fungi Infections Treatment Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Vaginal Fungi Infections Treatment Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Vaginal Fungi Infections Treatment Revenue Market Share by Type (2021-2026) Table 29. Global Vaginal Fungi Infections Treatment Revenue Market Share by Type (2027-2032) Table 30. Global Vaginal Fungi Infections Treatment Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Vaginal Fungi Infections Treatment Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Vaginal Fungi Infections Treatment Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Vaginal Fungi Infections Treatment Revenue Market Share by Application (2021-2026) Table 34. Global Vaginal Fungi Infections Treatment Revenue Market Share by Application (2027-2032) Table 35. ANI Pharmaceuticals Company Information Table 36. ANI Pharmaceuticals Business Overview Table 37. ANI Pharmaceuticals Vaginal Fungi Infections Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. ANI Pharmaceuticals Vaginal Fungi Infections Treatment Product Portfolio Table 39. ANI Pharmaceuticals Recent Development Table 40. Aurobindo Pharma Limited Company Information Table 41. Aurobindo Pharma Limited Business Overview Table 42. Aurobindo Pharma Limited Vaginal Fungi Infections Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Aurobindo Pharma Limited Vaginal Fungi Infections Treatment Product Portfolio Table 44. Aurobindo Pharma Limited Recent Development Table 45. Bausch Health Companies Inc Company Information Table 46. Bausch Health Companies Inc Business Overview Table 47. Bausch Health Companies Inc Vaginal Fungi Infections Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Bausch Health Companies Inc Vaginal Fungi Infections Treatment Product Portfolio Table 49. Bausch Health Companies Inc Recent Development Table 50. Dr. Reddy's Laboratories Company Information Table 51. Dr. Reddy's Laboratories Business Overview Table 52. Dr. Reddy's Laboratories Vaginal Fungi Infections Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Dr. Reddy's Laboratories Vaginal Fungi Infections Treatment Product Portfolio Table 54. Dr. Reddy's Laboratories Recent Development Table 55. Glenmark Pharmaceuticals Limited Company Information Table 56. Glenmark Pharmaceuticals Limited Business Overview Table 57. Glenmark Pharmaceuticals Limited Vaginal Fungi Infections Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Glenmark Pharmaceuticals Limited Vaginal Fungi Infections Treatment Product Portfolio Table 59. Glenmark Pharmaceuticals Limited Recent Development Table 60. Hikma Pharmaceuticals Plc Company Information Table 61. Hikma Pharmaceuticals Plc Business Overview Table 62. Hikma Pharmaceuticals Plc Vaginal Fungi Infections Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Hikma Pharmaceuticals Plc Vaginal Fungi Infections Treatment Product Portfolio Table 64. Hikma Pharmaceuticals Plc Recent Development Table 65. Lupin Limited Company Information Table 66. Lupin Limited Business Overview Table 67. Lupin Limited Vaginal Fungi Infections Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Lupin Limited Vaginal Fungi Infections Treatment Product Portfolio Table 69. Lupin Limited Recent Development Table 70. Mycovia Pharmaceuticals Company Information Table 71. Mycovia Pharmaceuticals Business Overview Table 72. Mycovia Pharmaceuticals Vaginal Fungi Infections Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Mycovia Pharmaceuticals Vaginal Fungi Infections Treatment Product Portfolio Table 74. Mycovia Pharmaceuticals Recent Development Table 75. PEPTONIC medical AB Company Information Table 76. PEPTONIC medical AB Business Overview Table 77. PEPTONIC medical AB Vaginal Fungi Infections Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. PEPTONIC medical AB Vaginal Fungi Infections Treatment Product Portfolio Table 79. PEPTONIC medical AB Recent Development Table 80. SCYNEXIS Company Information Table 81. SCYNEXIS Business Overview Table 82. SCYNEXIS Vaginal Fungi Infections Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. SCYNEXIS Vaginal Fungi Infections Treatment Product Portfolio Table 84. SCYNEXIS Recent Development Table 85. Unique Pharmaceuticals Company Information Table 86. Unique Pharmaceuticals Business Overview Table 87. Unique Pharmaceuticals Vaginal Fungi Infections Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Unique Pharmaceuticals Vaginal Fungi Infections Treatment Product Portfolio Table 89. Unique Pharmaceuticals Recent Development Table 90. Pfizer Inc. Company Information Table 91. Pfizer Inc. Business Overview Table 92. Pfizer Inc. Vaginal Fungi Infections Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Pfizer Inc. Vaginal Fungi Infections Treatment Product Portfolio Table 94. Pfizer Inc. Recent Development Table 95. North America Vaginal Fungi Infections Treatment Market Size by Type (2021-2026) & (US$ Million) Table 96. North America Vaginal Fungi Infections Treatment Market Size by Type (2027-2032) & (US$ Million) Table 97. North America Vaginal Fungi Infections Treatment Market Size by Application (2021-2026) & (US$ Million) Table 98. North America Vaginal Fungi Infections Treatment Market Size by Application (2027-2032) & (US$ Million) Table 99. North America Vaginal Fungi Infections Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. North America Vaginal Fungi Infections Treatment Market Size by Country (2021-2026) Table 101. North America Vaginal Fungi Infections Treatment Market Size by Country (2027-2032) Table 102. Europe Vaginal Fungi Infections Treatment Market Size by Type (2021-2026) & (US$ Million) Table 103. Europe Vaginal Fungi Infections Treatment Market Size by Type (2027-2032) & (US$ Million) Table 104. Europe Vaginal Fungi Infections Treatment Market Size by Application (2021-2026) & (US$ Million) Table 105. Europe Vaginal Fungi Infections Treatment Market Size by Application (2027-2032) & (US$ Million) Table 106. Europe Vaginal Fungi Infections Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. Europe Vaginal Fungi Infections Treatment Market Size by Country (2021-2026) Table 108. Europe Vaginal Fungi Infections Treatment Market Size by Country (2027-2032) Table 109. China Vaginal Fungi Infections Treatment Market Size by Type (2021-2026) & (US$ Million) Table 110. China Vaginal Fungi Infections Treatment Market Size by Type (2027-2032) & (US$ Million) Table 111. China Vaginal Fungi Infections Treatment Market Size by Application (2021-2026) & (US$ Million) Table 112. China Vaginal Fungi Infections Treatment Market Size by Application (2027-2032) & (US$ Million) Table 113. Asia Vaginal Fungi Infections Treatment Market Size by Type (2021-2026) & (US$ Million) Table 114. Asia Vaginal Fungi Infections Treatment Market Size by Type (2027-2032) & (US$ Million) Table 115. Asia Vaginal Fungi Infections Treatment Market Size by Application (2021-2026) & (US$ Million) Table 116. Asia Vaginal Fungi Infections Treatment Market Size by Application (2027-2032) & (US$ Million) Table 117. Asia Vaginal Fungi Infections Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 118. Asia Vaginal Fungi Infections Treatment Market Size by Country (2021-2026) Table 119. Asia Vaginal Fungi Infections Treatment Market Size by Country (2027-2032) Table 120. South America, Middle East & Africa Vaginal Fungi Infections Treatment Market Size by Type (2021-2026) & (US$ Million) Table 121. South America, Middle East & Africa Vaginal Fungi Infections Treatment Market Size by Type (2027-2032) & (US$ Million) Table 122. South America, Middle East & Africa Vaginal Fungi Infections Treatment Market Size by Application (2021-2026) & (US$ Million) Table 123. South America, Middle East & Africa Vaginal Fungi Infections Treatment Market Size by Application (2027-2032) & (US$ Million) Table 124. South America, Middle East & Africa Vaginal Fungi Infections Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. South America, Middle East & Africa Vaginal Fungi Infections Treatment Market Size by Country (2021-2026) Table 126. South America, Middle East & Africa Vaginal Fungi Infections Treatment Market Size by Country (2027-2032) Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Vaginal Fungi Infections Treatment Product Image Figure 2. Global Vaginal Fungi Infections Treatment Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Vaginal Fungi Infections Treatment Market Share by Type: 2025 VS 2032 Figure 4. Flucytosine Image Figure 5. Fluconazole Image Figure 6. Nystatin Image Figure 7. Others Image Figure 8. Global Vaginal Fungi Infections Treatment Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Vaginal Fungi Infections Treatment Market Share by Application: 2025 VS 2032 Figure 10. Hospital Pharmacies Image Figure 11. Online Pharmacies Image Figure 12. Retail Pharmacies Image Figure 13. Global Vaginal Fungi Infections Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Vaginal Fungi Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 15. Global Vaginal Fungi Infections Treatment Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Vaginal Fungi Infections Treatment Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Vaginal Fungi Infections Treatment Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Vaginal Fungi Infections Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Vaginal Fungi Infections Treatment Revenue Market Share by Type (2021-2032) Figure 22. Global Vaginal Fungi Infections Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Vaginal Fungi Infections Treatment Revenue Market Share by Application (2021-2032) Figure 24. North America Vaginal Fungi Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 25. North America Vaginal Fungi Infections Treatment Market Share by Type (2021-2032) Figure 26. North America Vaginal Fungi Infections Treatment Market Share by Application (2021-2032) Figure 27. North America Vaginal Fungi Infections Treatment Market Share by Country (2021-2032) Figure 28. United States Vaginal Fungi Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 29. Canada Vaginal Fungi Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Vaginal Fungi Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 31. Europe Vaginal Fungi Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 32. Europe Vaginal Fungi Infections Treatment Market Share by Type (2021-2032) Figure 33. Europe Vaginal Fungi Infections Treatment Market Share by Application (2021-2032) Figure 34. Europe Vaginal Fungi Infections Treatment Market Share by Country (2021-2032) Figure 35. Germany Vaginal Fungi Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 36. France Vaginal Fungi Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Vaginal Fungi Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 38. Italy Vaginal Fungi Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 39. Russia Vaginal Fungi Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Vaginal Fungi Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 41. China Vaginal Fungi Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 42. China Vaginal Fungi Infections Treatment Market Share by Type (2021-2032) Figure 43. China Vaginal Fungi Infections Treatment Market Share by Application (2021-2032) Figure 44. Asia Vaginal Fungi Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 45. Asia Vaginal Fungi Infections Treatment Market Share by Type (2021-2032) Figure 46. Asia Vaginal Fungi Infections Treatment Market Share by Application (2021-2032) Figure 47. Asia Vaginal Fungi Infections Treatment Market Share by Country (2021-2032) Figure 48. Japan Vaginal Fungi Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Vaginal Fungi Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Vaginal Fungi Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Vaginal Fungi Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 52. India Vaginal Fungi Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 53. Australia Vaginal Fungi Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Vaginal Fungi Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Vaginal Fungi Infections Treatment Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Vaginal Fungi Infections Treatment Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Vaginal Fungi Infections Treatment Market Share by Country (2021-2032) Figure 58. Brazil Vaginal Fungi Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Vaginal Fungi Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Vaginal Fungi Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Vaginal Fungi Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Vaginal Fungi Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 63. UAE Vaginal Fungi Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Vaginal Fungi Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 65. Chile Vaginal Fungi Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Flucytosine
  • Fluconazole
  • Nystatin
  • Others
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • ANI Pharmaceuticals
  • Aurobindo Pharma Limited
  • Bausch Health Companies Inc
  • Dr. Reddy's Laboratories
  • Glenmark Pharmaceuticals Limited
  • Hikma Pharmaceuticals Plc
  • Lupin Limited
  • Mycovia Pharmaceuticals
  • PEPTONIC medical AB
  • SCYNEXIS
  • Unique Pharmaceuticals
  • Pfizer Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Vaginal Fungi Infections Treatment Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Flucytosine
  5. 1.2.3 Fluconazole
  6. 1.2.4 Nystatin
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Vaginal Fungi Infections Treatment Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital Pharmacies
  11. 1.3.3 Online Pharmacies
  12. 1.3.4 Retail Pharmacies
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Vaginal Fungi Infections Treatment Growth Trends by Region
  15. 1.5.1 Global Vaginal Fungi Infections Treatment Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Vaginal Fungi Infections Treatment Market Size by Region (2021-2026)
  17. 1.5.3 Vaginal Fungi Infections Treatment Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Vaginal Fungi Infections Treatment Market Dynamics
  1. 2.1 Vaginal Fungi Infections Treatment Industry Trends
  2. 2.2 Vaginal Fungi Infections Treatment Industry Drivers
  3. 2.3 Vaginal Fungi Infections Treatment Industry Opportunities and Challenges
  4. 2.4 Vaginal Fungi Infections Treatment Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Vaginal Fungi Infections Treatment Revenue by Company (2021-2026)
  2. 3.2 Global Vaginal Fungi Infections Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Vaginal Fungi Infections Treatment Key Company Head office and Area Served
  4. 3.4 Global Vaginal Fungi Infections Treatment Company, Product Type & Application
  5. 3.5 Global Vaginal Fungi Infections Treatment Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Vaginal Fungi Infections Treatment Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Vaginal Fungi Infections Treatment Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Vaginal Fungi Infections Treatment Tier 1, Tier 2, and Tier 3
4 Vaginal Fungi Infections Treatment Market by Type
  1. 4.1 Global Vaginal Fungi Infections Treatment Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Vaginal Fungi Infections Treatment Market Size by Type (2021-2032)
  3. 4.3 Global Vaginal Fungi Infections Treatment Market Size Share by Type (2021-2032)
5 Vaginal Fungi Infections Treatment Market by Application
  1. 5.1 Global Vaginal Fungi Infections Treatment Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Vaginal Fungi Infections Treatment Market Size by Application (2021-2032)
  3. 5.3 Global Vaginal Fungi Infections Treatment Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 ANI Pharmaceuticals
  2. 6.1.1 ANI Pharmaceuticals Company Information
  3. 6.1.2 ANI Pharmaceuticals Business Overview
  4. 6.1.3 ANI Pharmaceuticals Vaginal Fungi Infections Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 ANI Pharmaceuticals Vaginal Fungi Infections Treatment Product Portfolio
  6. 6.1.5 ANI Pharmaceuticals Recent Developments
  7. 6.2 Aurobindo Pharma Limited
  8. 6.2.1 Aurobindo Pharma Limited Company Information
  9. 6.2.2 Aurobindo Pharma Limited Business Overview
  10. 6.2.3 Aurobindo Pharma Limited Vaginal Fungi Infections Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Aurobindo Pharma Limited Vaginal Fungi Infections Treatment Product Portfolio
  12. 6.2.5 Aurobindo Pharma Limited Recent Developments
  13. 6.3 Bausch Health Companies Inc
  14. 6.3.1 Bausch Health Companies Inc Company Information
  15. 6.3.2 Bausch Health Companies Inc Business Overview
  16. 6.3.3 Bausch Health Companies Inc Vaginal Fungi Infections Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Bausch Health Companies Inc Vaginal Fungi Infections Treatment Product Portfolio
  18. 6.3.5 Bausch Health Companies Inc Recent Developments
  19. 6.4 Dr. Reddy's Laboratories
  20. 6.4.1 Dr. Reddy's Laboratories Company Information
  21. 6.4.2 Dr. Reddy's Laboratories Business Overview
  22. 6.4.3 Dr. Reddy's Laboratories Vaginal Fungi Infections Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Dr. Reddy's Laboratories Vaginal Fungi Infections Treatment Product Portfolio
  24. 6.4.5 Dr. Reddy's Laboratories Recent Developments
  25. 6.5 Glenmark Pharmaceuticals Limited
  26. 6.5.1 Glenmark Pharmaceuticals Limited Company Information
  27. 6.5.2 Glenmark Pharmaceuticals Limited Business Overview
  28. 6.5.3 Glenmark Pharmaceuticals Limited Vaginal Fungi Infections Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Glenmark Pharmaceuticals Limited Vaginal Fungi Infections Treatment Product Portfolio
  30. 6.5.5 Glenmark Pharmaceuticals Limited Recent Developments
  31. 6.6 Hikma Pharmaceuticals Plc
  32. 6.6.1 Hikma Pharmaceuticals Plc Company Information
  33. 6.6.2 Hikma Pharmaceuticals Plc Business Overview
  34. 6.6.3 Hikma Pharmaceuticals Plc Vaginal Fungi Infections Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Hikma Pharmaceuticals Plc Vaginal Fungi Infections Treatment Product Portfolio
  36. 6.6.5 Hikma Pharmaceuticals Plc Recent Developments
  37. 6.7 Lupin Limited
  38. 6.7.1 Lupin Limited Company Information
  39. 6.7.2 Lupin Limited Business Overview
  40. 6.7.3 Lupin Limited Vaginal Fungi Infections Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Lupin Limited Vaginal Fungi Infections Treatment Product Portfolio
  42. 6.7.5 Lupin Limited Recent Developments
  43. 6.8 Mycovia Pharmaceuticals
  44. 6.8.1 Mycovia Pharmaceuticals Company Information
  45. 6.8.2 Mycovia Pharmaceuticals Business Overview
  46. 6.8.3 Mycovia Pharmaceuticals Vaginal Fungi Infections Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Mycovia Pharmaceuticals Vaginal Fungi Infections Treatment Product Portfolio
  48. 6.8.5 Mycovia Pharmaceuticals Recent Developments
  49. 6.9 PEPTONIC medical AB
  50. 6.9.1 PEPTONIC medical AB Company Information
  51. 6.9.2 PEPTONIC medical AB Business Overview
  52. 6.9.3 PEPTONIC medical AB Vaginal Fungi Infections Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 PEPTONIC medical AB Vaginal Fungi Infections Treatment Product Portfolio
  54. 6.9.5 PEPTONIC medical AB Recent Developments
  55. 6.10 SCYNEXIS
  56. 6.10.1 SCYNEXIS Company Information
  57. 6.10.2 SCYNEXIS Business Overview
  58. 6.10.3 SCYNEXIS Vaginal Fungi Infections Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 SCYNEXIS Vaginal Fungi Infections Treatment Product Portfolio
  60. 6.10.5 SCYNEXIS Recent Developments
  61. 6.11 Unique Pharmaceuticals
  62. 6.11.1 Unique Pharmaceuticals Company Information
  63. 6.11.2 Unique Pharmaceuticals Business Overview
  64. 6.11.3 Unique Pharmaceuticals Vaginal Fungi Infections Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Unique Pharmaceuticals Vaginal Fungi Infections Treatment Product Portfolio
  66. 6.11.5 Unique Pharmaceuticals Recent Developments
  67. 6.12 Pfizer Inc.
  68. 6.12.1 Pfizer Inc. Company Information
  69. 6.12.2 Pfizer Inc. Business Overview
  70. 6.12.3 Pfizer Inc. Vaginal Fungi Infections Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Pfizer Inc. Vaginal Fungi Infections Treatment Product Portfolio
  72. 6.12.5 Pfizer Inc. Recent Developments
7 North America
  1. 7.1 North America Vaginal Fungi Infections Treatment Market Size (2021-2032)
  2. 7.2 North America Vaginal Fungi Infections Treatment Market Size by Type
  3. 7.2.1 North America Vaginal Fungi Infections Treatment Market Size by Type (2021-2026)
  4. 7.2.2 North America Vaginal Fungi Infections Treatment Market Size by Type (2027-2032)
  5. 7.2.3 North America Vaginal Fungi Infections Treatment Market Share by Type (2021-2032)
  6. 7.3 North America Vaginal Fungi Infections Treatment Market Size by Application
  7. 7.3.1 North America Vaginal Fungi Infections Treatment Market Size by Application (2021-2026)
  8. 7.3.2 North America Vaginal Fungi Infections Treatment Market Size by Application (2027-2032)
  9. 7.3.3 North America Vaginal Fungi Infections Treatment Market Share by Application (2021-2032)
  10. 7.4 North America Vaginal Fungi Infections Treatment Market Size by Country
  11. 7.4.1 North America Vaginal Fungi Infections Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Vaginal Fungi Infections Treatment Market Size by Country (2021-2026)
  13. 7.4.3 North America Vaginal Fungi Infections Treatment Market Size by Country (2027-2032)
  14. 7.4.4 North America Vaginal Fungi Infections Treatment Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Vaginal Fungi Infections Treatment Market Size (2021-2032)
  2. 8.2 Europe Vaginal Fungi Infections Treatment Market Size by Type
  3. 8.2.1 Europe Vaginal Fungi Infections Treatment Market Size by Type (2021-2026)
  4. 8.2.2 Europe Vaginal Fungi Infections Treatment Market Size by Type (2027-2032)
  5. 8.2.3 Europe Vaginal Fungi Infections Treatment Market Share by Type (2021-2032)
  6. 8.3 Europe Vaginal Fungi Infections Treatment Market Size by Application
  7. 8.3.1 Europe Vaginal Fungi Infections Treatment Market Size by Application (2021-2026)
  8. 8.3.2 Europe Vaginal Fungi Infections Treatment Market Size by Application (2027-2032)
  9. 8.3.3 Europe Vaginal Fungi Infections Treatment Market Share by Application (2021-2032)
  10. 8.4 Europe Vaginal Fungi Infections Treatment Market Size by Country
  11. 8.4.1 Europe Vaginal Fungi Infections Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Vaginal Fungi Infections Treatment Market Size by Country (2021-2026)
  13. 8.4.3 Europe Vaginal Fungi Infections Treatment Market Size by Country (2027-2032)
  14. 8.4.4 Europe Vaginal Fungi Infections Treatment Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Vaginal Fungi Infections Treatment Market Size (2021-2032)
  2. 9.2 China Vaginal Fungi Infections Treatment Market Size by Type
  3. 9.2.1 China Vaginal Fungi Infections Treatment Market Size by Type (2021-2026)
  4. 9.2.2 China Vaginal Fungi Infections Treatment Market Size by Type (2027-2032)
  5. 9.2.3 China Vaginal Fungi Infections Treatment Market Share by Type (2021-2032)
  6. 9.3 China Vaginal Fungi Infections Treatment Market Size by Application
  7. 9.3.1 China Vaginal Fungi Infections Treatment Market Size by Application (2021-2026)
  8. 9.3.2 China Vaginal Fungi Infections Treatment Market Size by Application (2027-2032)
  9. 9.3.3 China Vaginal Fungi Infections Treatment Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Vaginal Fungi Infections Treatment Market Size (2021-2032)
  2. 10.2 Asia Vaginal Fungi Infections Treatment Market Size by Type
  3. 10.2.1 Asia Vaginal Fungi Infections Treatment Market Size by Type (2021-2026)
  4. 10.2.2 Asia Vaginal Fungi Infections Treatment Market Size by Type (2027-2032)
  5. 10.2.3 Asia Vaginal Fungi Infections Treatment Market Share by Type (2021-2032)
  6. 10.3 Asia Vaginal Fungi Infections Treatment Market Size by Application
  7. 10.3.1 Asia Vaginal Fungi Infections Treatment Market Size by Application (2021-2026)
  8. 10.3.2 Asia Vaginal Fungi Infections Treatment Market Size by Application (2027-2032)
  9. 10.3.3 Asia Vaginal Fungi Infections Treatment Market Share by Application (2021-2032)
  10. 10.4 Asia Vaginal Fungi Infections Treatment Market Size by Country
  11. 10.4.1 Asia Vaginal Fungi Infections Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Vaginal Fungi Infections Treatment Market Size by Country (2021-2026)
  13. 10.4.3 Asia Vaginal Fungi Infections Treatment Market Size by Country (2027-2032)
  14. 10.4.4 Asia Vaginal Fungi Infections Treatment Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Vaginal Fungi Infections Treatment Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Vaginal Fungi Infections Treatment Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Vaginal Fungi Infections Treatment Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Vaginal Fungi Infections Treatment Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Vaginal Fungi Infections Treatment Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Vaginal Fungi Infections Treatment Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Vaginal Fungi Infections Treatment Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Vaginal Fungi Infections Treatment Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Vaginal Fungi Infections Treatment Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Vaginal Fungi Infections Treatment Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Vaginal Fungi Infections Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Vaginal Fungi Infections Treatment Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Vaginal Fungi Infections Treatment Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Vaginal Fungi Infections Treatment Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst